Cilostazol and Mexiletine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cilostazol (cilostazol) and Mexiletine hydrochloride (mexiletine hydrochloride). Common drug interactions include alopecia totalis among females and agranulocytosis among males.

The phase IV clinical study analyzes what interactions people have when they take Cilostazol and Mexiletine hydrochloride. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Cilostazol?

Cilostazol has active ingredients of cilostazol. It is often used in arteriosclerosis of the extremities. eHealthMe is studying from 7,877 Cilostazol users. Check the latest studies of Cilostazol.

What is Mexiletine hydrochloride?

Mexiletine hydrochloride has active ingredients of mexiletine hydrochloride. eHealthMe is studying from 766 Mexiletine hydrochloride users. Check the latest studies of Mexiletine hydrochloride.

On Jul, 20, 2026

25 people who take Cilostazol and Mexiletine hydrochloride together, and have interactions are studied.

Cilostazol and Mexiletine hydrochloride drug interactions.

What are the common drug interactions of Cilostazol and Mexiletine Hydrochloride, by gender? *:

female:

Alopecia totalis (loss of all head hair)
Decreased appetite
Delirium (wild excitement)
Dementia (madness)
Depression
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Fall
Gait abnormal
Gastric ulcer haemorrhage (bleeding ulcer of stomach)
Haematocrit

male:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Anxiety
Acute promyelocytic leukaemia (cancer of the blood and bone marrow)
Alanine aminotransferase increased
Anaemia (lack of blood)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Aspartate aminotransferase increased
Blood albumin decreased
Blood alkaline phosphatase increased
Blood bilirubin increased

What are the common drug interactions of Cilostazol and Mexiletine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Alopecia totalis (loss of all head hair)

60+:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Anxiety
Acute promyelocytic leukaemia (cancer of the blood and bone marrow)
Alanine aminotransferase increased
Anaemia (lack of blood)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Aspartate aminotransferase increased
Blood albumin decreased
Blood alkaline phosphatase increased
Blood bilirubin increased

What are the existing conditions these people have? *

Diabetes: 5 people, 20.00%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 5 people, 20.00%
Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 8.00%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 2 people, 8.00%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 8.00%
Hyperchlorhydria (gastric acid levels are higher in stomach): 2 people, 8.00%
Acute Promyelocytic Leukaemia (cancer of the blood and bone marrow): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cilostazol and Mexiletine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously